Skip to main content
. 2017 Oct 10;8(55):94619–94634. doi: 10.18632/oncotarget.21816

Figure 3. LY2510924 peptide induced mobilization of WBCs, neutrophils, and HSCs in mice.

Figure 3

Analysis of LY2510924 (peptide antagonist) induced, dose-dependent changes vs. vehicle at 3 hours in (A) WBCs and (B) neutrophils. ED50 of LY2510924 (peptide antagonist) induced changes in (C) total WBCs and (D) neutrophils. Analysis of LY2510924 (peptide antagonist) induced, time-dependent changes at 5 mg/kg vs. vehicle (3 hours) in (E) total WBCs and (F) neutrophils. (G) HSC mobilization induced by LY2510924 (peptide antagonist) acetate salt form (LSN2534820) measured by CFU.